Seeing Is Believing
Currently out of the existing stock ratings of Daniel Grosslight, 91 are a BUY (56.17%), 67 are a HOLD (41.36%), 4 are a SELL (2.47%).
Analyst Daniel Grosslight, currently employed at CITI, carries an average stock price target met ratio of 62.99% that have a potential upside of 30.18% achieved within 186 days.
Daniel Grosslight’s has documented 325 price targets and ratings displayed on 23 stocks. The coverage is on Healthcare, Financial Services, Consumer Defensive, Consumer Cyclical, Communication Services sectors.
Most recent stock forecast was given on GDRX, Goodrx Holdings at 13-Nov-2024.
Analyst best performing recommendations are on HIMS (HIMS HERS HEALTH).
The best stock recommendation documented was for HIMS (HIMS HERS HEALTH) at 5/22/2024. The price target of $20 was fulfilled within 8 days with a profit of $15.4 (334.78%) receiving and performance score of 418.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$27.75
2 years 2 months 16 days ago
(20-Sep-2022)
6/7 (85.71%)
$5.58 (25.17%)
151
Hold
$27.75
$0.26 (0.95%)
$26
2 years 2 months 16 days ago
(20-Sep-2022)
1/2 (50%)
$2.62 (10.43%)
125
Hold
$27.75
$0.26 (0.95%)
$18
2 years 2 months 29 days ago
(07-Sep-2022)
1/2 (50%)
$4.77 (20.76%)
534
Hold
$27.75
$0.26 (0.95%)
$26
2 years 6 months 5 days ago
(31-May-2022)
1/2 (50%)
$5.42 (24.27%)
181
Buy
$26
$-1.49 (-5.42%)
$21
2 years 11 months 3 days ago
(03-Jan-2022)
6/6 (100%)
$6.63 (34.23%)
290
Which stock is Daniel Grosslight is most bullish on?
Which stock is Daniel Grosslight is most reserved on?
What Year was the first public recommendation made by Daniel Grosslight?